Search Within

Timothy Chan

  1. "Biostatistics Service"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (13)
  3. Research Letter (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (56)
  2. Biostatistics Service (56)
  3. Epidemiology and Biostatistics (56)
  4. GSK Faculty (56)
  5. Department of Medicine (35)
  6. Human Oncology and Pathogenesis Program (32)

More Groups

People
  1. Kathryn Beal (15)
  2. Luc Morris (15)
  3. Abraham Hakimi (13)
  4. Fengshen Kuo (13)
  5. Nadeem Riaz (13)
  6. Zhigang Zhang (12)

More People

Years
  1. 2022 (4)
  2. 2021 (7)
  3. 2020 (6)
  4. 2019 (5)
  5. 2018 (4)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. International Journal of Radiation Oncology, Biology, Physics (6)
  3. Clinical Cancer Research (5)
  4. Nature Communications (4)
  5. Nature (3)
  6. Nature Genetics (3)

More Publications

Publishers
  1. Nature Publishing Group (11)
  2. Elsevier Inc. (9)
  3. American Association for Cancer Research (8)
  4. American Society of Clinical Oncology (8)
  5. Oxford University Press (5)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM)
    Meeting Abstract

    Graber, J. J.; Young, R. J.; Gupta, A.; Shah, A. D.; Chan, T. A.; Zhang, Z.; Shi, W.; Beal, K.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Breast cancer methylomes establish an epigenomic foundation for metastasis
    Journal Article

    Fang, F.; Turcan, S.; Rimner, A.; Kaufman, A.; Giri, D.; Morris, L. G. T.; Shen, R.; Seshan, V.; Mo, Q.; Heguy, A.; more...
    Science Translational Medicine (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M.; Beal, K.; Karimi, S.; Chan, T. A.; Panageas, K.; Nayak, L.; Seko, B.; DeAngelis, L. M.; Abrey, L. E.; Gutin, P. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Hypofractionated IMRT for large, difficult brain metastases
    Meeting Abstract

    Beal, K. P.; Yamada, Y.; Chan, T. A.; Zhang, Z.; Shi, W.; Cruz, J.; Brennan, C.; Tabar, V.; Gutin, P. H.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save